Perspective Therapeutics (CATX) Total Current Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Total Current Liabilities across 16 years of filings, most recently posting $36.5 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 181.41% year-over-year to $36.5 million; the TTM figure through Jun 2026 stood at $36.5 million (up 181.41% YoY), while the FY2025 annual figure was $28.7 million, up 57.32% from the prior year.
• Total Current Liabilities came in at $36.5 million for Q2 2026 at Perspective Therapeutics, up from $31.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $36.5 million in Q2 2026 to a low of $2.0 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $14.7 million, with a median of $12.8 million recorded in 2025.
• Year-over-year, Total Current Liabilities jumped 402.37% in 2023 and retreated 26.74% in 2025.
• Over 5 years, Total Current Liabilities stood at $3.1 million in 2022, then jumped by 402.37% to $15.7 million in 2023, then rose by 16.38% to $18.2 million in 2024, then surged by 57.32% to $28.7 million in 2025, then gained by 27.42% to $36.5 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $36.5 million in Q2 2026, $31.5 million in Q1 2026, and $28.7 million in Q4 2025.